Functional imaging of pharmacological action of SGLT2 inhibitor ipragliflozin via PET imaging using <sup>11</sup>C-MDG.

Mitsuoka, Keisuke; Hayashizaki, Yuka; Murakami, Yoshihiro; Takasu, Toshiyuki; Yokono, Masanori; Umeda, Nobuhiro; Takakura, Shoji; Noda, Akihiro; Miyoshi, Sosuke

Functional imaging of pharmacological action of SGLT2 inhibitor ipragliflozin via PET imaging using ¹¹C-MDG.

Mitsuoka, Keisuke; Hayashizaki, Yuka; Murakami, Yoshihiro; Takasu, Toshiyuki; Yokono, Masanori; Umeda, Nobuhiro; Takakura, Shoji; Noda, Akihiro; Miyoshi, Sosuke.

Afiliación

Mitsuoka K; Drug Discovery Research Astellas Pharma Inc. Tsukuba Japan.
Hayashizaki Y; Drug Discovery Research Astellas Pharma Inc. Tsukuba Japan.
Murakami Y; Drug Discovery Research Astellas Pharma Inc. Tsukuba Japan.
Takasu T; Drug Discovery Research Astellas Pharma Inc. Tsukuba Japan.
Yokono M; Drug Discovery Research Astellas Pharma Inc. Tsukuba Japan.
Umeda N; Drug Discovery Research Astellas Pharma Inc. Tsukuba Japan.
Takakura S; Drug Discovery Research Astellas Pharma Inc. Tsukuba Japan.
Noda A; Drug Discovery Research Astellas Pharma Inc. Tsukuba Japan.
Miyoshi S; Drug Discovery Research Astellas Pharma Inc. Tsukuba Japan.

Pharmacol Res Perspect ; 4(4): e00244, 2016 Aug.

Article en En | MEDLINE | ID: mdl-28116097

Palabras clave

Ipragliflozin and visualization; MDG; PET; SGLT2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Pharmacol Res Perspect Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google